How is the Iterum Therapeutics Plc today?

The Iterum Therapeutics Plc today is trading in the down by 0.00% at 0.94.

How has Iterum Therapeutics Plc performed historically?

The Iterum Therapeutics Plc is currently trading down 0.00% on an intraday basis in the past week the index fell -6.00%. The index has been down -37.33% in the past quarter and fell -38.16% in the past year. You can view this in the overview section.

What is Iterum Therapeutics Plc Annual Net Profit?

Iterum Therapeutics Plc Annual Net Profit rose 35.44% in the last year to $24.77 M. Its sector's average net profit growth for the last fiscal year was -7.19%.

What is Iterum Therapeutics Plc Price to Earning Ratio?

Iterum Therapeutics Plc Price to Earning Ratio is -1.31, which is negative.

What is Iterum Therapeutics Plc Stock Price?

Iterum Therapeutics Plc Stock Price fell 38.16% and underperformed its sector by 43.64% in the past year.

What is Iterum Therapeutics Plc Quarterly Net profit?

Iterum Therapeutics Plc Quarterly Net profit rose 46.76% YoY to $6.58 M. Its sector's average net profit growth YoY for the quarter was -210.52%.

What is Iterum Therapeutics Plc Mutual Fund Holding?

Iterum Therapeutics Plc Mutual Fund Holding remained the same in the last quarter at 0.14%.

What is Iterum Therapeutics Plc Promoter Share Holding?

Iterum Therapeutics Plc Promoter Share Holding stayed the same in the most recent quarter at 2.58%.

What is Iterum Therapeutics Plc Interest Coverage Ratio?

Iterum Therapeutics Plc Interest Coverage Ratio is -8.73, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Iterum Therapeutics Plc Institutional Holding?

Iterum Therapeutics Plc Institutional Holding decreased by 0% in the last quarter to 3.43.

Iterum Therapeutics Plc XNAS: ITRM

Iterum Therapeutics Plc Live Share Price Today, Share Analysis and Chart

Name: Iterum Therapeutics Plc: Is Infosys Ltd. worth buying?
Item: Iterum Therapeutics Plc
Rating: 0.67450
Author: Trendlyne DVM scores

about

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem availabl...

0.94 0.00 (0.00%)

68.87% Fall from 52W High

84,794 XNAS Volume

XNAS 14 May, 2025 10:20 AM (EDT)

Board Meeting

The latest board meeting for Iterum Therapeutics Plc took place on 13 May 2025, for the purpose of Iterum Therapeutics PLC First Quarter Earnings Result for 2025 See details

Not Eligible

Expensive Valuation

0.0 / 100

Technically Bearish

27.0 / 100

No estimates available

Iterum Therapeutics Plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Iterum Therapeutics Plc Live Share Price Today, Share Analysis and Chart

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem availabl...

68.87% Fall from 52W High

SWOT Analysis

Iterum Therapeutics Plc Live Price Chart

Iterum Therapeutics Plc FAQ

How is Iterum Therapeutics Plc today?

Iterum Therapeutics Plc today is trading in the red, and is down by 0.00% at 0.94.

How has Iterum Therapeutics Plc performed historically?

Iterum Therapeutics Plc is currently trading down 0.00% on an intraday basis. In the past week the stock fell -6.00%. stock has been down -37.33% in the past quarter and fell -38.16% in the past year. You can view this in the overview section.